Head-to-head · Value Score
Alan Meds vs NuuVim
Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, NuuVim a 77. Here's who gives you the honest lower price — and where each one bites back.
Alan Meds
#7 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameNuuVim
#108 · Grade B- · Fair Price
Est. first month
From $79/mo (all doses, compounded)
Save ~94% vs brand-nameThe verdict
Alan Meds takes it on Value Score, 90 to 77 — an est. $99/mo first month, with no teaser step-up baked in. NuuVim isn't out of it: Shoppers who want low-cost compounded GLP-1s (injection or oral), flat all-dose pricing.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Alan Meds | NuuVim |
|---|---|---|
| Value Score | 90 (A) | 77 (B-) |
| Est. first month | $99/mo | From $79/mo (all doses, compounded) |
| Save vs brand-name | ~93% | ~94% |
| Semaglutide | $99/mo | From $79/mo (all doses, compounded) |
| Tirzepatide | $145/mo | From $133/mo (all doses, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Alan Meds
Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.
Why it's a deal
- $99 flat semaglutide and a low $145 tirzepatide
- Available in all 50 states
- Offers an oral/sublingual route
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Newer operator with a thin public track record
NuuVim
NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.
Why it's a deal
- Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
- Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
- LegitScript Certified and HIPAA-compliant
- Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
- Operating legal entity disclosed: NuuVim LLC, Texas governing law
The fine print
- No founder, CEO, medical director, or pharmacist-in-charge named
- Refund and cancellation policy not surfaced on the site
- Compounded medications are not FDA-approved
- Doesn't disclose which pharmacy fills which drug or form
- FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Alan Meds is ranked on the Alan Meds alternatives board, and the same list for the other side is on alternatives to NuuVim.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.